Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0002057997-25-000002
Filing Date
2025-11-21
Accepted
2025-11-21 21:26:11
Documents
1
Period of Report
2024-05-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 3959
  Complete submission text file 0002057997-25-000002.txt   5589
Mailing Address 100 MATAWAN RD SUITE 325 MATAWAN NJ 07747
Business Address 100 MATAWAN RD SUITE 325 MATAWAN NJ 07747 848-201-5010
Apimeds Pharmaceuticals US, Inc. (Issuer) CIK: 0001894525 (see all company filings)

EIN.: 851099700 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ROOM 613, DIGITAL-RO 130, 6F GEUMCHEON-GU SEOUL M5 08580
Business Address ROOM 613, DIGITAL-RO 130, 6F GEUMCHEON-GU SEOUL M5 08580 82-70-7600-7007
Inscobee Inc. (Reporting) CIK: 0002057997 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-42545 | Film No.: 251509433